亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Domain of a Protein Antigen from Coccidioides immitis which Induces Protection Against Coccidoidal Infection

詳細技術說明
Title: Domain of a Coccidioides immitis Protein Antigen which Induces Protection Against Coccidioidal InfectionBackground: Coccidioidomycosis ensues after infection with the fungus Coccidioides immitis ("Valley Fever"). The body is usually able to resolve the infection without treatment within a few weeks to a few months, and the individual's immune system is almost completely resistant to a second infection. However, some cases are unable to resolve the infection and must succumb to extensive and sometimes lifelong antifungal treatment. A vaccine to C. immitis has been tested but resulted in excessive pain and inflammation at the injection site making the method unacceptable. Development of a more potent vaccination against C. immitis infection would enable researchers to create a low dose vaccine in turn alleviating problems with pain and inflammation.Applications:*Development of a potent targeted vaccine to C. immitis Advantages:*Identification of a protein antigen domain of C. immitis that confers resistance reducing the amount of vaccine required in turn decreasing the negative side effects associated with vaccinationThe Technology: Researchers at the University of Arizona have determined the precise conformation required to confer resistance to C. immitis or Valley Fever, which is endemic to Southwestern United States, Mexico and other Latin American countries. They have identified a subunit of C. immitis antigen that would both prevent coccidioidomycosis and optimize the vaccine dose in turn reducing any negative side effects from vaccination. Injecting an individual with an antigenic subunit eliminates the presence of unneeded genetic sequences from the vaccine. This reduces the risks associated with the more common whole-cell vaccine injection.
*Abstract
None
*Principal Investigation

Name: John Galgiani, Director

Department: Valley Fever Center for Excellence


Name: Kris Orsborn, Research Specialist, Senior

Department: Valley Fever Center for Excellence


Name: Tao Peng, Research Specialist, Senior

Department: Valley Fever Center for Excellence


Name: Lisa Shubitz, Associate Research Professor

Department: Veterinary Science & Microbiology

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備